XML 43 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Segments
6 Months Ended
Dec. 31, 2019
Business Segments  
Business Segments

12.  Business Segments

We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development.

We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.

The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months

 

Six Months

For the Periods Ended December 31

    

2019

    

2018

    

2019

    

2018

Net sales

 

 

  

 

 

  

 

 

  

 

 

  

Animal Health

 

$

143,689

 

$

139,562

 

$

265,539

 

$

270,751

Mineral Nutrition

 

 

55,685

 

 

62,319

 

 

108,334

 

 

117,157

Performance Products

 

 

14,638

 

 

16,342

 

 

29,859

 

 

30,468

Total segments

 

$

214,012

 

$

218,223

 

$

403,732

 

$

418,376

Depreciation and amortization

 

 

  

 

 

  

 

 

  

 

 

  

Animal Health

 

$

6,711

 

$

5,493

 

$

13,095

 

$

10,849

Mineral Nutrition

 

 

629

 

 

616

 

 

1,242

 

 

1,213

Performance Products

 

 

417

 

 

279

 

 

794

 

 

552

Total segments

 

$

7,757

 

$

6,388

 

$

15,131

 

$

12,614

Adjusted EBITDA

 

 

  

 

 

  

 

 

  

 

 

  

Animal Health

 

$

33,838

 

$

35,925

 

$

58,899

 

$

71,641

Mineral Nutrition

 

 

3,684

 

 

4,084

 

 

7,159

 

 

6,647

Performance Products

 

 

1,457

 

 

1,514

 

 

2,309

 

 

2,230

Total segments

 

$

38,979

 

$

41,523

 

$

68,367

 

$

80,518

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of income before income taxes to Adjusted EBITDA

    

 

  

    

 

  

 

 

  

 

 

  

Income before income taxes

 

$

16,895

 

$

20,074

 

$

20,467

 

$

42,779

Interest expense, net

 

 

3,432

 

 

3,015

 

 

6,786

 

 

5,798

Depreciation and amortization – Total segments

 

 

7,757

 

 

6,388

 

 

15,131

 

 

12,614

Depreciation and amortization – Corporate

 

 

391

 

 

453

 

 

798

 

 

918

Corporate costs

 

 

10,491

 

 

9,918

 

 

20,219

 

 

18,804

Restructure costs

 

 

 —

 

 

 —

 

 

425

 

 

 —

Stock-based compensation

 

 

564

 

 

564

 

 

1,129

 

 

1,129

Acquisition-related cost of goods sold

 

 

 —

 

 

 —

 

 

280

 

 

 —

Acquisition-related transaction costs

 

 

 —

 

 

 —

 

 

462

 

 

 —

Acquisition-related other

 

 

167

 

 

 —

 

 

167

 

 

 —

Other, net

 

 

 —

 

 

(1,506)

 

 

 —

 

 

(1,506)

Foreign currency (gains) losses, net

 

 

(718)

 

 

2,617

 

 

2,503

 

 

(18)

Adjusted EBITDA – Total segments

 

$

38,979

 

$

41,523

 

$

68,367

 

$

80,518

 

 

 

 

 

 

 

 

 

    

December 31, 

    

June 30, 

As of

 

2019

 

2019

Identifiable assets

 

 

  

 

 

  

Animal Health

 

$

572,921

 

$

508,864

Mineral Nutrition

 

 

69,988

 

 

67,662

Performance Products

 

 

33,530

 

 

32,886

Total segments

 

 

676,439

 

 

609,412

Corporate

 

 

111,879

 

 

117,259

Total

 

$

788,318

 

$

726,671

 

The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of $3,548 and $3,287 as of December 31, 2019 and June 30, 2019, respectively. The Performance Products segment includes an investment in an equity method investee of $852 and $759 as of December 31, 2019 and June 30, 2019, respectively. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax related assets and certain other assets.